CochLear - 16 Year Stock Price History | CHEOY
Historical daily share price chart and data for CochLear since 2009 adjusted for splits and dividends. The latest closing stock price for CochLear as of May 15, 2025 is 86.38.
- The all-time high CochLear stock closing price was 112.00 on July 15, 2024.
- The CochLear 52-week high stock price is 113.74, which is 31.7% above the current share price.
- The CochLear 52-week low stock price is 74.76, which is 13.5% below the current share price.
- The average CochLear stock price for the last 52 weeks is 96.48.
| CochLear Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 87.5000 | 90.4376 | 98.9296 | 75.1800 | 86.3800 | -2.96% |
| 2024 | 101.4100 | 99.6716 | 111.9970 | 89.0162 | 89.0162 | -10.74% |
| 2023 | 78.7557 | 65.5080 | 100.8480 | 65.5080 | 99.7235 | 49.26% |
| 2022 | 69.9347 | 73.9312 | 83.7154 | 55.8788 | 66.8132 | -10.66% |
| 2021 | 79.0936 | 68.6176 | 89.5132 | 65.5608 | 74.7851 | 9.01% |
| 2020 | 66.1240 | 73.4147 | 82.1935 | 43.1590 | 68.6053 | -6.67% |
| 2019 | 64.8959 | 55.9923 | 75.7868 | 54.6836 | 73.5050 | 31.52% |
| 2018 | 63.6476 | 60.0480 | 71.5894 | 52.1165 | 55.8880 | -7.34% |
| 2017 | 52.0668 | 39.4085 | 63.9148 | 39.4085 | 60.3164 | 53.80% |
| 2016 | 38.6701 | 29.9094 | 48.0168 | 27.2446 | 39.2185 | 30.12% |
| 2015 | 27.8868 | 26.9052 | 31.3033 | 24.8434 | 30.1408 | 11.86% |
| 2014 | 24.0673 | 21.4913 | 28.8138 | 19.7255 | 26.9459 | 25.64% |
| 2013 | 24.8604 | 32.7849 | 33.7863 | 20.2357 | 21.4465 | -33.60% |
| 2012 | 26.3853 | 24.4016 | 32.4845 | 22.3938 | 32.2981 | 34.44% |
| 2011 | 26.7805 | 30.0668 | 33.2896 | 16.3274 | 24.0243 | -20.85% |
| 2010 | 25.0558 | 20.2382 | 30.3516 | 20.2382 | 30.3516 | 38.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.282B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |